Sacral neuromodulation in children and adolescents with defecation disorders

Besendoerfer, Manuel and Knorr, Christian and Kirchgatter, Annemarie and Mueller, Hanna and Wolfertstetter, Patricia Reis and Matzel, Klaus E. and Diez, Sonja (2024) Sacral neuromodulation in children and adolescents with defecation disorders. NEUROGASTROENTEROLOGY AND MOTILITY, 36 (6). ISSN 1350-1925, 1365-2982

Full text not available from this repository. (Request a copy)

Abstract

Background: Even if understanding of neuronal enteropathies, such as Hirschsprung's disease and functional constipation, has been improved, specialized therapies are still missing. Sacral neuromodulation (SNM) has been established in the treatment of defecation disorders in adults. The aim of the study was to investigate effects of SNM in children and adolescents with refractory symptoms of chronic constipation. Methods: A two-centered, prospective trial has been conducted between 2019 and 2022. SNM was applied continuously at individually set stimulation intensity. Evaluation of clinical outcomes was conducted at 3, 6, and 12 months after surgery based on the developed questionnaires and quality of life analysis (KINDLR). Primary outcome was assessed based on predefined variables of fecal incontinence and defecation frequency. Key Results: Fifteen patients enrolled in the study and underwent SNM (median age 8.0 years (range 4-17 years)): eight patients were diagnosed with Hirschsprung's disease (53%). Improvement of defecation frequency was seen in 8/15 participants (53%) and an improvement of fecal incontinence in 9/12 patients (75%). We observed stable outcome after 1 year of treatment. Surgical revision was necessary in one patient after electrode breakage. Urinary incontinence was observed as singular side effect of treatment in two patients (13%), which was manageable with the reduction of stimulation intensity. Conclusions: SNM shows promising clinical results in children and adolescents presenting with chronic constipation refractory to conservative therapy. Indications for patients with enteral neuropathies deserve further confirmation.

Item Type: Article
Uncontrolled Keywords: QUALITY-OF-LIFE; FECAL INCONTINENCE; NERVE-STIMULATION; CONSTIPATION; NEUROGASTROENTEROLOGY; MANAGEMENT; DIAGNOSIS; DISEASE; enteral neuropathies; fecal incontinence; Hirschsprung's disease; sacral nerve stimulation; sacral neuromodulation
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Orthopädie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 20 Aug 2025 09:49
Last Modified: 20 Aug 2025 09:49
URI: https://pred.uni-regensburg.de/id/eprint/65522

Actions (login required)

View Item View Item